We've launched a new site so please go to People & Research for current information on our faculty and staff.

Mark B McClellan, Professor of the Practice of Business Administration  

Office Location: Margolis Center for Health Policy, JB Duke Buildkng, 230 Science Drive, Durham,
Email Address: mark.mcclellan@duke.edu
Web Page: http://www.fuqua.duke.edu/faculty/mark-mcclellan
Web Page: https://healthpolicy.duke.edu/

Areas of Expertise

    Education:
    Ph.D., Massachusetts Institute of Technology, 1993
    M.D., Harvard Medical School, 1992
    M.P.A., Harvard University, 1991
    B.A., University of Texas, Austin, 1985

    Recent Publications   (More Publications)

    1. Pencina, MJ; Silcox, C; Economou-Zavlanos, N; McClellan, M. "Bridging the Gap Between Developers and Implementers in Health AI.." JAMA Health Forum 6.6 (June, 2025): e251692. [doi]
    2. Shapiro, LM; Bozic, KJ; McClellan, M; Spindler, K. "The New Centers for Medicare and Medicaid Services Patient-Reported Outcome-Based Performance Measure: What It Means and How Can I Align.." The Journal of the American Academy of Orthopaedic Surgeons 33.10 (May, 2025): e541-e550. [doi]  [abs]
    3. Gottlieb, S; McClellan, MB. "Why a Planned Reorganization of the FDA Creates Major Challenges.." JAMA health forum 6.5 (May, 2025): e252326. [doi]
    4. Nafie, M; Parker, VJ; McClellan, M; Hendricks-Sturrup, RM. "A Brief Report on Proposed Areas of International Harmonization of Real-World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators.." Pharmacoepidemiology and drug safety 34.3 (March, 2025): e70127. [doi]  [abs]
    5. McClellan, M; DeSalvo, KB; Benjamin, GC; Cerise, FP; Choucair, B; Del Rio, C; Harrison, M; Medows, R; Ranney, ML; Zink, A. "Updating US Public Health For Healthier Communities.." Health affairs (Project Hope) 44.2 (February, 2025): 148-155. [doi]  [abs]

    Highlight:

    Mark McClellan, MD, PhD, is a physician-economist who focuses on quality and value in health care, including payment and coverage reform, real-world evidence, more effective policies to support drug and device innovation, and initiatives to increase the impact of health care, public health, and social service programs on population health. His work on responding to the COVID-19 public health emergency spanned virus containment and testing strategies, reforming health care toward more resilient models of delivering care, and accelerating the development of therapeutics and vaccines, including a COVID-19 response roadmap. He is former commissioner of the U.S. Food and Drug Administration, and former administrator of the Centers for Medicare & Medicaid Services, where he developed and implemented major reforms in health policy. He has also served as a member of the President’s Council of Economic Advisors and as a Deputy Assistant Secretary for Economic Policy at the Department of the Treasury. He was previously Associate Professor of Economics with tenure at Stanford University.  Dr. McClellan is an independent board member on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; chairs the National Academy of Medicine’s Leadership Consortium for a Value and Science-Driven Health System; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and serves as an advisor for Blackstone Life Sciences, Arsenal Capital Partners, and MITRE.

     

    Mark B McClellan

    x